Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,104 | 582 | 376 | 341 | 457 |
| Cost of Goods | 62 | 80 | 713 | 512 | 26 |
| Gross Profit | 1,042 | 502 | -337 | -171 | 431 |
| Operating Expenses | 18,400 | 24,745 | 20,249 | 48,638 | 52,871 |
| Operating Income | -17,296 | -24,163 | -19,873 | -48,297 | -52,414 |
| Interest Expense | 3,700 | 3,607 | 3,436 | 3,252 | 3,259 |
| Other Income | 12,697 | 979 | 1,053 | 1,063 | 2,158 |
| Pre-tax Income | -8,299 | -26,791 | -22,256 | -50,486 | -53,515 |
| Net Income Continuous | -8,299 | -26,791 | -22,256 | -50,486 | -53,515 |
| Net Income | $-8,299 | $-26,791 | $-22,256 | $-50,486 | $-53,515 |
| EPS Basic Total Ops | -3.30 | -13.89 | -12.09 | -27.52 | -29.28 |
| EPS Basic Continuous Ops | -3.30 | -13.89 | -11.87 | -27.60 | -29.34 |
| EPS Diluted Total Ops | -3.30 | -13.89 | -12.09 | -27.52 | -29.28 |
| EPS Diluted Continuous Ops | -3.30 | -13.89 | -11.87 | -27.60 | -29.34 |
| EPS Diluted Before Non-Recurring Items | -3.36 | -13.92 | -12.16 | N/A | N/A |
| EBITDA(a) | $-17,219 | $-24,085 | $-19,795 | $-48,218 | $-52,333 |